San Carlos, CA, United States of America

Andrew Shinohara

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrew Shinohara: Innovator in Genomic User Interfaces

Introduction

Andrew Shinohara is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of genomic data through his innovative user interface designs. With a total of 2 patents, Shinohara is recognized for his work that enhances the interaction between users and genomic information.

Latest Patents

Shinohara's latest patents include the "Genomic Network Service User Interface" and the "Cross-Network Genomic Data User Interface." The Genomic Network Service User Interface patent describes a genomic update system that generates a user interface from network pages based on user variant data. This system tracks network services for different trait categories, allowing users to interact with content through their devices. The Cross-Network Genomic Data User Interface patent outlines a similar concept, where a user interface is generated based on variant data matching user information. This interface includes visualizations and content from trusted network pages, enhancing user engagement.

Career Highlights

Andrew Shinohara is currently employed at Helix Opco, LLC, where he continues to develop innovative solutions in genomic data management. His work focuses on creating user-friendly interfaces that facilitate the understanding and utilization of complex genomic information.

Collaborations

Shinohara collaborates with talented individuals such as Keith Dunaway and Anna Merkoulovitch, contributing to a dynamic team environment that fosters innovation.

Conclusion

Andrew Shinohara's contributions to genomic user interfaces exemplify the intersection of technology and biology. His patents reflect a commitment to improving user interaction with genomic data, paving the way for advancements in personalized medicine and data accessibility.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…